BEGIN:VCALENDAR VERSION:2.0 PRODID:VideoCast CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VEVENT SUMMARY:Pathway Directed Treatment Strategies in Kidney Cancer DTSTART:20180316T160000Z DTEND:20180316T170000Z DTSTAMP:20180312T172800Z UID:Videocast--26300 LOCATION:https://videocast.nih.gov/watch=26300 DESCRIPTION:Ramaprasad Srinivasan\, MD\, PhD\, Investigator\, Urologic Oncology Branch\, Center for Cancer Research\, NCI\, NIH\nNCI’s Center for Cancer Research (CCR) Grand Rounds \n\nDr. Srinivasan is an Investigator in the Urologic Oncology Branch\, National Cancer Institute (NCI). He obtained his M.D. from the Bangalore Medical College in India and completed his Ph.D. in biomedical sciences at the University of Texas MD Anderson Cancer Center in Houston. He came to NCI in 1999 after completing his Internal Medicine Residency training at the University of Texas Health Science Center-Houston to pursue a fellowship in Medical Oncology/Hematology. After completing his fellowship\, he joined the Urologic Oncology Branch where he is developing treatment strategies and clinical trials for patients with both hereditary and non-hereditary forms of kidney cancer. He is currently investigating a variety of newer 'targeted' agents in clear cell and papillary kidney cancer\, as well as hereditary kidney cancer syndromes such as von Hippel-Lindau\, hereditary leiomyomatosis and renal cell cancer and hereditary papillary renal cell cancer (HPRC). X-ALT-DESC;FMTTYPE=text/html:\n\n
\n